Treace Medical Concepts, Inc. (NASDAQ: TMCI) is a Healthcare company (Medical - Devices) with a market capitalization of $291M. The Maz Rating grades it against the other companies in its sector.
Treace Medical Concepts, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $4.44, Treace Medical Concepts, Inc. trades at 1.4x sales and 4.7x book value. Over the last twelve months it generated about $203M of revenue and a net loss of $56M. It runs a gross margin of 79.6%, an operating margin of -24.4% and a net margin of -27.4%. It shows return on equity of -75.9%, return on invested capital of -35.6% and a free cash flow yield of -6.4%. On the balance sheet: a debt-to-equity ratio of 1.21 and a current ratio of 2.58. Over the past 52 weeks the share price ranged from $1.17 to $5.44, with a beta of 1.56.
Treace Medical Concepts, Inc. does not currently pay a dividend.
9 Wall Street analyst ratings cover the stock: 3 Buy, 5 Hold and 1 Sell, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.